Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.62
-0.20 (-1.45%)
May 13, 2025, 4:08 PM HKT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Laboratory Services
6.66B
Log In
Log In
Log In
Log In
Laboratory Services Growth
6.65%
Log In
Log In
Log In
Log In
Chemical and Formulation Process Development and Production Services
2.71B
Log In
Log In
Log In
Log In
Chemical and Formulation Process Development and Production Services Growth
12.64%
Log In
Log In
Log In
Log In
Clinical Research Services
1.74B
Log In
Log In
Log In
Log In
Clinical Research Services Growth
24.66%
Log In
Log In
Log In
Log In
Macromolecule and Cell and Gene Therapy Services
424.94M
Log In
Log In
Log In
Log In
Macromolecule and Cell and Gene Therapy Services Growth
117.76%
Log In
Log In
Log In
Log In
Other
4.61M
Log In
Log In
Log In
Log In
Other Growth
-82.39%
Log In
Log In
Log In
Log In
Other
4.61M
Log In
Log In
Log In
Log In
Other Growth
-82.39%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Other
48.87M
Log In
Log In
Log In
Log In
Other Growth
95.40%
Log In
Log In
Log In
Log In
North America
7.40B
Log In
Log In
Log In
Log In
North America Growth
11.39%
Log In
Log In
Log In
Log In
China
1.97B
Log In
Log In
Log In
Log In
China Growth
5.02%
Log In
Log In
Log In
Log In
Europe
1.84B
Log In
Log In
Log In
Log In
Europe Growth
24.35%
Log In
Log In
Log In
Log In
Asia (Excluding Mainland China)
269.04M
Log In
Log In
Log In
Log In
Asia (Excluding Mainland China) Growth
15.23%
Log In
Log In
Log In
Log In
Other
48.87M
Log In
Log In
Log In
Log In
Other Growth
95.40%
Log In
Log In
Log In
Log In